Literature DB >> 7219487

Control of antibody-mediated pure red-cell aplasia by plasmapheresis.

H A Messner, A A Fauser, J E Curtis, D Dotten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7219487     DOI: 10.1056/NEJM198105283042205

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Pathology-important advances in clinical medicine: assessing fetal lung maturity.

Authors:  R K Wertz
Journal:  West J Med       Date:  1984-07

2.  Plasmapheresis in clinical medicine.

Authors:  C Linker
Journal:  West J Med       Date:  1983-01

Review 3.  Pure red cell aplasia: review of treatment and proposal for a treatment strategy.

Authors:  A Raghavachar
Journal:  Blut       Date:  1990 Aug-Sep

4.  Serum erythropoietic inhibitors in patients with pure red cell aplasia.

Authors:  M Takahashi; K Nikkuni; I Tanaka; T Furukawa; Y Moriyama; A Shibata; S Satoh; Y Kuwabara; Y Maruyama; Y Matsunaga
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

5.  Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas.

Authors:  O Prümmer; N Frickhofen; W Digel; H Heimpel; F Porzsolt
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

6.  The nonspecific clearance function of the reticuloendothelial system in patients with immune complex mediated diseases before and after therapeutic plasmapheresis.

Authors:  A Löw; A Hotze; F Krapf; W Schranz; B J Manger; J Mahlstedt; F Wolf; J R Kalden
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

7.  [Clinical analysis of 32 patients with acquired pure red cell aplasia].

Authors:  J F Chen; J M Kang; Y F Zhang; M F Wang; C X Dong; L Y Wang; L P Guo; L H Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

8.  Pathophysiologic Mechanisms And Management Of Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia.

Authors:  Zhi-Yuan Qiu; Rong Qin; Guang-Yu Tian; Yan Wang; Ye-Qing Zhang
Journal:  Onco Targets Ther       Date:  2019-10-04       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.